|Articles|February 19, 2014

PAREXEL Launches New Regulatory Outsourcing Service Line

PAREXEL has announced its Regulatory Outsourcing Services

PAREXEL has announced its Regulatory Outsourcing Services, a customized service for clients, with an emphasis on post-approval regulatory activities. The service line is within the PAREXEL Consulting business segment. Rick Riegel, Corporate Vice President is the new head of the PAREXEL Regulatory Outsourcing Services line, which will be based on client's unique needs and business pressures.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

PAREXEL Launches New Regulatory Outsourcing Service Line

Related Content

Vaccine Trials at an Inflection Point: Operational, Regulatory, and Public Trust Challenges

ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps

A Shot in the Arm to Traditional Vaccine Trial Strategy

SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years

ACT Brief: Site-First Technology Strategy, AI Data Harmonization Architecture, and Obesity Trial Retention

Trending on Applied Clinical Trials Online

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps

SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years

A Shot in the Arm to Traditional Vaccine Trial Strategy

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention